Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Aastrom Biosciences, Inc. (NasdaqNM:ASTM)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Msgs | Insider | Financials
Location
24 Frank Lloyd Wright Drive
P.O. Box 376
Ann Arbor, MI 48106
Phone: (734) 930-5555
Fax: (734) 665-0485
Email: mail@aastrom.com
Employees (last reported count): 30
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 56%
·Over the last 6 months:
 · one insider buy; 5,000  shares
 · one insider sell; 3,000  shares
·Institutional: 3% (6% of float)
(23 institutions)
·Net Inst. Buying: 157.0K shares (+15.45%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Aastrom Biosciences, Inc. is developing proprietary process technologies and devices intended for a broad range of cell therapy applications. The AastromReplicell System is the Company's lead product under development, and consists of a clinical cell culture system that operates single-use therapy kits tailored for patient therapy in the emerging cell therapy market. Aastrom is currently developing its own SC-I Therapy Kit, CB-I Therapy Kit and CB-II Therapy Kit for use in stem cell therapy in cancer patients. Stem cell therapy is a form of cell therapy used to restore blood and immune system function to cancer patients following chemotherapy or radiation therapy.
More from Market Guide: Expanded Business Description

Financial Summary
ASTM is developing automated clinical systems designed to enable therapeutic procedures using living cells in the treatment of cancer and other diseases and in the restoration of normal tissues. For the fiscal year ended 6/30/01, revenues fell 22% to $899 thousand. Net loss applicable to Common fell 38% to $5.9 million. Revenues reflect lower product sales and rentals and grant revenues. Lower loss reflects lower R&D costs for the AastromReplicell System and cost reduction measures.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

R. Douglas Armstrong, Ph.D., 47
Chairman, Pres, CEO
$496K--  
Brian Hampson, 43
VP, Product Devel.
160K$32K
Bruce Husel, 42
VP Quality Systems and Regulatory Affairs
154K184K
Audrey Hutter
VP, Market Operations
--  --  
Dollar amounts are as of 30-June-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ASTMAs of 31-Aug-2001
Price and Volume
52-Week Low
on 9-Apr-2001
$0.75 
Recent Price$1.15 
52-Week High
on 15-Sep-2000
$4.375
Beta1.60 
Daily Volume (3-month avg)1.09M
Daily Volume (10-day avg)575.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-64.6%
52-Week Change
relative to S&P500
-52.5%
Share-Related Items
Market Capitalization$39.3M
Shares Outstanding34.2M
Float15.0M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.31 
Earnings (ttm)-$0.17 
Earnings (mrq)-$0.05 
Sales (ttm)$0.03 
Cash (mrq)$0.31 
Valuation Ratios
Price/Book (mrq)3.67 
Price/EarningsN/A 
Price/Sales (ttm)43.53 
Income Statements
Sales (ttm)$899.0K
EBITDA (ttm)-$6.58M
Income available to common (ttm)-$5.93M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsJune 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-50.25%
Return on Equity (ttm)-54.64%
Financial Strength
Current Ratio (mrq)11.60 
Debt/Equity (mrq)0 
Total Cash (mrq)$10.7M
Short Interest
As of 8-Aug-2001
Shares Short1.67M
Percent of Float11.1%
Shares Short
(Prior Month)
1.47M
Short Ratio1.01 
Daily Volume1.65M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.